Effect of dimethyl fumarate in patients with plaque psoriasis meeting the upgrade criteria required for moderate‐to‐severe disease classification
Abstract Background Oral dimethyl fumarate (DMF) is indicated in patients with plaque psoriasis requiring systemic treatment, including those meeting the upgrade criteria for moderate‐to‐severe disease classification. Objectives To evaluate quality of life (QoL), effectiveness, and tolerability of D...
Spremljeno u:
| Glavni autori: | , , , |
|---|---|
| Format: | Knjiga |
| Izdano: |
Wiley,
2024-12-01T00:00:00Z.
|
| Teme: | |
| Online pristup: | Connect to this object online. |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
Internet
Connect to this object online.3rd Floor Main Library
| Signatura: |
A1234.567 |
|---|---|
| Primjerak 1 | Dostupno |